Cronos Group (NASDAQ: CRON)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Cronos Group (NASDAQ: CRON) through any online brokerage.
There are no as such competitors for Cronos Group.
The latest price target for Cronos Group (NASDAQ: CRON) was reported by Barclays on Tuesday, March 22, 2022. The analyst firm set a price target for 0.00 expecting CRON to fall to within 12 months (a possible -100.00% downside). 6 analyst firms have reported ratings in the last year.
The stock price for Cronos Group (NASDAQ: CRON) is $3.1 last updated August 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Cronos Group.
Cronos Group’s Q2 earnings are confirmed for Tuesday, August 9, 2022.
There is no upcoming split for Cronos Group.
Cronos Group is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.